Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Brandon L Pierce

Showing results (1-10 of 106) with videos related to

Pageof 11
Sort By:
Elife|April 28, 2022
The aging epigenomeBrandon L Pierce
Urologic Oncology|October 2, 2012
Why are diabetics at reduced risk for prostate cancer? A review of the epidemiologic evidenceBrandon L Pierce
Cancer Research|April 19, 2011
Genome-wide "pleiotropy scan" identifies HNF1A region as a novel pancreatic cancer susceptibility locusBrandon L Pierce, Habibul Ahsan
Genetic Epidemiology|May 13, 2009
Case-only genome-wide interaction study of disease risk, prognosis and treatmentBrandon L Pierce, Habibul Ahsan
Neurobiology of Aging|January 29, 2014
Genetic susceptibility to accelerated cognitive decline in the US Health and Retirement StudyChenan Zhang, Brandon L Pierce
Lancet (London, England)|September 14, 2010
Clinical assessment incorporating a personal genomeBrandon L Pierce, Habibul Ahsan
American Journal of Epidemiology|July 19, 2013
Efficient design for Mendelian randomization studies: subsample and 2-sample instrumental variable estimatorsBrandon L Pierce, Stephen Burgess
Human Heredity|March 6, 2010
Genetic susceptibility to type 2 diabetes is associated with reduced prostate cancer riskBrandon L Pierce, Habibul Ahsan
International Journal of Epidemiology|October 10, 2012
The effect of non-differential measurement error on bias, precision and power in Mendelian randomization studiesBrandon L Pierce, Tyler J VanderWeele
Current Epidemiology Reports|July 24, 2018
Mendelian randomization studies of cancer risk: a literature reviewBrandon L Pierce, Peter Kraft, Chenan Zhang
Pageof 11

Showing results (1-10 of 106) with videos related to

Sort By:
Pageof 11
Elife|April 28, 2022
The aging epigenomeBrandon L Pierce
Urologic Oncology|October 2, 2012
Why are diabetics at reduced risk for prostate cancer? A review of the epidemiologic evidenceBrandon L Pierce
Cancer Research|April 19, 2011
Genome-wide "pleiotropy scan" identifies HNF1A region as a novel pancreatic cancer susceptibility locusBrandon L Pierce, Habibul Ahsan
Genetic Epidemiology|May 13, 2009
Case-only genome-wide interaction study of disease risk, prognosis and treatmentBrandon L Pierce, Habibul Ahsan
Neurobiology of Aging|January 29, 2014
Genetic susceptibility to accelerated cognitive decline in the US Health and Retirement StudyChenan Zhang, Brandon L Pierce
Lancet (London, England)|September 14, 2010
Clinical assessment incorporating a personal genomeBrandon L Pierce, Habibul Ahsan
American Journal of Epidemiology|July 19, 2013
Efficient design for Mendelian randomization studies: subsample and 2-sample instrumental variable estimatorsBrandon L Pierce, Stephen Burgess
Human Heredity|March 6, 2010
Genetic susceptibility to type 2 diabetes is associated with reduced prostate cancer riskBrandon L Pierce, Habibul Ahsan
International Journal of Epidemiology|October 10, 2012
The effect of non-differential measurement error on bias, precision and power in Mendelian randomization studiesBrandon L Pierce, Tyler J VanderWeele
Current Epidemiology Reports|July 24, 2018
Mendelian randomization studies of cancer risk: a literature reviewBrandon L Pierce, Peter Kraft, Chenan Zhang
Pageof 11